Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 25, 2022
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
[ Tue, Oct 25th 2022
] - WOPRAI
Gil Blum Maintained (TSHA) at Strong Buy with Decreased Target to $18 on, Oct 25th, 2022
Gil Blum of Needham, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $20 to $18 on, Oct 25th, 2022.
Gil has made no other calls on TSHA in the last 4 months.
There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Gil
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $32 on, Friday, August 12th, 2022
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $5 on, Friday, August 12th, 2022
